Boston Scientific (BSX)
NYSE:BSX
Want to see BSX full AI Analyst Report?
Total Valuation
Boston Scientific has a market cap or net worth of $70.87B. The enterprise value is $81.31B.
Market Cap$70.87B
Enterprise Value$81.31B
Share Statistics
Boston Scientific has 1,486,355,200 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,486,355,200
Owned by Insiders0.13%
Owned by Institutions20.65%
Financial Efficiency
Boston Scientific’s return on equity (ROE) is 0.12 and return on invested capital (ROIC) is 8.78%.
Return on Equity (ROE)0.12
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)8.78%
Return on Capital Employed (ROCE)0.10
Revenue Per Employee378.75K
Profits Per Employee54.57K
Employee Count53,000
Asset Turnover0.46
Inventory Turnover2.11
Valuation Ratios
The current PE Ratio of Boston Scientific is 19.9. Boston Scientific’s PEG ratio is 0.88.
PE Ratio19.9
PS Ratio7.03
PB Ratio5.82
Price to Fair Value5.82
Price to FCF38.59
Price to Operating Cash Flow16.31
PEG Ratio0.88
Income Statement
In the last 12 months, Boston Scientific had revenue of 20.07B and earned 2.89B in profits. Earnings per share was 1.96.
Revenue20.07B
Gross Profit13.85B
Operating Income3.97B
Pretax Income3.38B
Net Income2.89B
EBITDA3.73B
Earnings Per Share (EPS)1.96
Cash Flow
In the last 12 months, operating cash flow was 4.34B and capital expenditures -899.00M, giving a free cash flow of 3.44B billion.
Operating Cash Flow4.34B
Free Cash Flow3.44B
Free Cash Flow per Share2.32
Dividends & Yields
Boston Scientific pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.68
52-Week Price Change-53.44%
50-Day Moving Average58.78
200-Day Moving Average84.39
Relative Strength Index (RSI)27.63
Average Volume (3m)22.11M
Important Dates
Boston Scientific upcoming earnings date is Jul 29, 2026, Before Open (Confirmed).
Last Earnings DateApr 22, 2026
Next Earnings DateJul 29, 2026
Ex-Dividend Date―
Financial Position
Boston Scientific as a current ratio of 1.62, with Debt / Equity ratio of 42.64%
Current Ratio1.62
Quick Ratio1.08
Debt to Market Cap0.08
Net Debt to EBITDA2.78
Interest Coverage Ratio11.38
Taxes
In the past 12 months, Boston Scientific has paid 493.00M in taxes.
Income Tax493.00M
Effective Tax Rate0.15
Enterprise Valuation
Boston Scientific EV to EBITDA ratio is 40.59, with an EV/FCF ratio of 41.42.
EV to Sales7.55
EV to EBITDA40.59
EV to Free Cash Flow41.42
EV to Operating Cash Flow33.42
Balance Sheet
Boston Scientific has $1.52B in cash and marketable securities with $11.03B in debt, giving a net cash position of -$9.51B billion.
Cash & Marketable Securities$1.52B
Total Debt$11.03B
Net Cash-$9.51B
Net Cash Per Share-$6.39
Tangible Book Value Per Share-$0.56
Margins
Gross margin is 70.41%, with operating margin of 19.78%, and net profit margin of 14.38%.
Gross Margin70.41%
Operating Margin19.78%
Pretax Margin16.86%
Net Profit Margin14.38%
EBITDA Margin18.60%
EBIT Margin18.60%
Analyst Forecast
The average price target for Boston Scientific is $81.64, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$81.64
Price Target Upside27.10% Upside
Analyst ConsensusStrong Buy
Analyst Count27
Revenue Growth Forecast17.44%
EPS Growth Forecast74.36%